Background
Methods
Settings, patients and infection surveillance policies
Outbreak investigation of MSSA infections
Epidemiology
Ethical considerations
Results
SA epidemiology in the NCC
NICU | PRICU | Kangaroo ward | Total | |||||
---|---|---|---|---|---|---|---|---|
n | % | n | % | n | % | n | % | |
Sites of isolation | ||||||||
Respiratory | 4 | 20 | 39 | 63.9 | 2 | 40 | 45 | 52.3 |
Ophthalmic | 9 | 45 | 4 | 6.6 | 2 | 40 | 15 | 17.5 |
Blood | 2 | 10 | 8 | 13.1 | 0 | 0 | 10 | 11.6 |
Catheter | 2 | 10 | 5 | 8.2 | 0 | 0 | 7 | 8.1 |
Other | 3 | 15 | 5 | 8.2 | 1 | 20 | 9 | 10.5 |
Total | 20 | 61 | 5 | 86 |
MSSA infections outbreak
Patient | Reason of admission | Samples | Nature of sample | NCC sector | PFGE profile | MSSA/MRSA |
luk-PV
|
sea
|
tst
| Penicilline G | Oxacilline | Kanamycin | Gentamicin | Tobramycin | Tetracycline | Macrolides | Cotrimoxazole | Fluoroquinolones | Rifamycin | Fusic acid | Fosfomycin | Glycopeptides | Linezolid |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Prematurity and NEC | 1A | BSI | NICU | A | MSSA | S | S | S | S | S | S | S | S | S | S | S | S | S | S | |||
1B | PRICU | B | MSSA | R | S | S | S | S | S | S | S | S | S | S | S | S | ND | ||||||
2 | Severe epileptic encephalopathy | 2A | BSI | PRICU | C | MSSA | R | S | S | S | S | S | S | S | S | S | S | S | S | S | |||
2B | Conjunctivitis | C | MSSA | + | R | S | S | S | S | S | S | S | S | S | S | S | S | S | |||||
3 | Prematurity and NEC | 3A | Insertion point of KT | PRICU | C | MSSA | R | S | S | S | S | S | S | S | S | S | S | S | S | ND | |||
3B | KT | C | MSSA | ND | ND | ND | R | S | S | S | S | S | S | S | S | S | S | S | S | ND | |||
3C | C | MSSA | ND | ND | ND | R | S | S | S | S | S | S | S | S | S | S | S | S | ND | ||||
4 | Prematurity | 4A | BSI | PRICU | Untypable | MSSA | R | S | S | S | S | S | S | S | S | S | S | S | S | S | |||
4B | Untypable | MSSA | ND | ND | ND | R | S | S | S | S | S | S | S | S | S | S | S | S | S | ||||
5 | Prematurity | 5A | Tracheal Asp. | PRICU | C | MSSA | R | S | S | S | S | S | S | S | S | S | S | S | S | ND | |||
5B | BL | C | MSSA | + | R | S | S | S | S | S | R | S | S | S | S | S | S | S | |||||
6 | Severe epileptic encephalopathy | 6A | Tracheal Asp. | PRICU | C | MSSA | - | R | S | S | S | S | S | S | S | S | S | S | S | S | S |
Actions | Dates |
---|---|
Case study | August 07, 17 and 18, 2009 |
- Clinical records review and strains typing | |
Environmental investigation | August 05, 12, September 15 and October 13, 2009 |
- Surface and water sampling | |
- Gowns | December 2009 (retrospectively) |
Hygiene practices assessment | October 01, 2009 |
- Hand hygiene | October 19, 24 and November 09, 2009 |
- Catheter-linked practices |